İntrahepatik Kolestaz Tanılı Gebelerde Perinatal Sonuçlar: Son Üç Yılın Verileriyle Retrospektif Bir Değerlendirme

Öz

Bu retrospektif kohort çalışmada, intrahepatik kolestaz tanısı almış gebeliklerde maternal ve neonatal sonuçlar değerlendirilmiş ve bu bulgular, yaş, parite ve tanı haftası açısından eşleştirilmiş sağlıklı gebeliklerle karşılaştırılmıştır. Ocak 2022 ile Ocak 2025 tarihleri arasında Türkiye’de bir üçüncü basamak sağlık merkezinde takip edilen 70 intrahepatik kolestazlı gebe ile 240 sağlıklı kontrol gebelik çalışmaya dahil edilmiştir. Maternal demografik veriler, laboratuvar bulguları, obstetrik özellikler ve neonatal sonuçlar karşılaştırılmış; ayrıca safra asidi düzeyinin şiddetine ve tanı zamanına (erken ya da geç başlangıç) göre alt grup analizleri yapılmıştır. Bulgular, intrahepatik kolestazın preterm doğum, düşük doğum ağırlığı, yenidoğan yoğun bakım ünitesine yatış oranı ve Apgar skorlarında düşüş gibi olumsuz perinatal sonuçlarla anlamlı şekilde ilişkili olduğunu göstermiştir. Şiddetli kolestaz (≥100 μmol/L), daha erken doğum ve daha yüksek düşük doğum ağırlığı insidansı ile bağlantılı bulunmuştur. Erken başlangıçlı olgularda ise daha sık mekonyumla boyanmış amniyon sıvısı ve daha düşük kordon pH değerleri saptanmıştır. Ursodeoksikolik asit tedavisi yaygın olarak uygulanmış olsa da, özellikle şiddetli ve erken başlangıçlı olgularda tedaviye yanıt sınırlı kalmıştır. Sonuç olarak, intrahepatik kolestaz, özellikle erken başlangıçlı ya da yüksek safra asidi düzeyine sahip olgularda ciddi perinatal riskler oluşturmaktadır. Bu nedenle erken tanı, düzenli safra asidi izlemi ve bireyselleştirilmiş obstetrik yönetim önerilmektedir. Tanı eşiklerinin netleştirilmesi ve doğum planlamasının optimize edilmesi için ileriye dönük çalışmalara ihtiyaç vardır.

Anahtar Kelimeler

• Gebelik kolestazı
• Safra asitleri
• Erken doğum
• Yenidoğan sonuçları
• Perinatal morbidite

Perinatal Outcomes in Pregnancies Diagnosed with Intrahepatic Cholestasis: A Retrospective Analysis Based on the Last Three Years of Data

Öz

This retrospective cohort study aimed to evaluate maternal and neonatal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy (ICP) and to compare them with matched healthy controls. A total of 70 women diagnosed with ICP and 240 controls matched for age, parity, and year were included. All participants were followed at a tertiary care center in Turkey between January 2022 and January 2025. Maternal demographics, laboratory results, obstetric characteristics, and neonatal outcomes were assessed. Subgroup analyses were conducted according to the severity of bile acid elevation and the timing of ICP diagnosis (early vs. late onset). The presence of ICP was significantly associated with increased rates of preterm delivery (35.7% vs. 5.8%, p<0.001), lower birth weight (2888±371 g vs. 3295±467 g, p<0.001), higher NICU admission (30% vs. 7.9%, p<0.001), and reduced Apgar scores. Severe ICP (≥100 μmol/L) correlated with earlier delivery and a higher incidence of low birth weight (71.4%, p<0.001). Early-onset ICP was linked to a higher frequency of meconium-stained amniotic fluid and lower cord pH levels. Although ursodeoxycholic acid (UDCA) therapy was commonly administered, clinical response remained limited in severe and early-onset cases. In conclusion, ICP is significantly associated with adverse perinatal outcomes, particularly when presenting early or with severe bile acid elevation. Early diagnosis, close monitoring of bile acid levels, and individualized management strategies may help reduce fetal risks. Further prospective studies are warranted to clarify diagnostic thresholds and optimize the timing of delivery.

Anahtar Kelimeler

• Intrahepatic cholestasis of pregnancy
• Bile acids
• Preterm birth
• Neonatal outcomes
• Perinatal morbidity

Kaynakça

1. 1. Williamson C, Geenes V. Intrahepatic Cholestasis of Pregnancy. Obstetrics & Gynecology. 2014 Jul;124(1):120–33.
2. 2. Xiao J, Li Z, Song Y, Sun Y, Shi H, Chen D, et al. Molecular Pathogenesis of Intrahepatic Cholestasis of Pregnancy. Canadian Journal of Gastroenterology and Hepatology. 2021;2021(1):6679322.
3. 3. Smith DD, Rood KM. Intrahepatic Cholestasis of Pregnancy. Clinical Obstetrics & Gynecology. 2020 Mar;63(1):134–51.
4. 4. Wood AM, Livingston EG, Hughes BL, Kuller JA. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management. Obstetrical & Gynecological Survey. 2018 Feb;73(2):103–9.
5. 5. Glantz A, Marschall HU, Mattsson LÅ. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology. 2004 Aug;40(2):467–74.
6. 6. Feng C, Li WJ, He RH, Sun XW, Wang G, Wang LQ. Impacts of different methods of conception on the perinatal outcome of intrahepatic cholestasis of pregnancy in twin pregnancies. Sci Rep. 2018 Mar 5;8(1):3985.
7. 7. Ma Z, Liu Y, Chai L, Jin G, Sun Y, Zhou S, et al. Metabolic changes in bile acids with pregnancy progression and their correlation with perinatal complications in intrahepatic cholestasis of pregnant patients. Sci Rep. 2023 Jan 28;13(1):1608.
8. 8. You S, Cui AM, Hashmi SF, Zhang X, Nadolny C, Chen Y, et al. Dysregulation of bile acids increases the risk for preterm birth in pregnant women. Nat Commun. 2020 Apr 30;11(1):2111.

9. 9. Ovadia C, Sajous J, Seed PT, Patel K, Williamson NJ, Attilakos G, et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. The Lancet Gastroenterology & Hepatology. 2021 Jul 1;6(7):547–58.
10. 10. Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2018 Dec;231:180–7.
11. 11. Arthuis C, Diguisto C, Lorphelin H, Dochez V, Simon E, Perrotin F, et al. Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study. PLOS ONE. 2020 Feb 19;15(2):e0228213.
12. 12. Jhirwal M, Sharma C, Shekhar S, Singh P, Meena SP, Kathuria P, et al. Maternal and Perinatal Outcome in Pregnancy Complicated by Intrahepatic Cholestasis. Cureus. 14(8):e28512.
13. 13. Rook M, Vargas J, Caughey A, Bacchetti P, Rosenthal P, Bull L. Fetal Outcomes in Pregnancies Complicated by Intrahepatic Cholestasis of Pregnancy in a Northern California Cohort. PLOS ONE. 2012 Mar 5;7(3):e28343.
14. 14. Wikström Shemer E, Marschall H, Ludvigsson J, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG: An International Journal of Obstetrics & Gynaecology. 2013;120(6):717–23.
15. 15. Shao X, Tang H, Xiu Y, Ren K, Pan M. Determinants of pregnancy outcomes in early-onset intrahepatic cholestasis of pregnancy. Journal of Perinatal Medicine. 2025 Mar 1;53(3):332–7.
16. 16. Hocaoglu M, Bulut ,Ozgul, Unal ,Irem, Inanc Karaman ,Gokcem, Unsal Kaya ,Dilan, and Turgut A. Early- and Late-Onset Intrahepatic Cholestasis of Pregnancy: A Comparison of Maternal and Neonatal Outcomes. Fetal and Pediatric Pathology. 2025 Mar 4;44(2):114–30.
17. 17. Luo M, Tang M, Jiang F, Jia Y, Chin RKH, Liang W, et al. Intrahepatic Cholestasis of Pregnancy and Associated Adverse Maternal and Fetal Outcomes: A Retrospective Case-Control Study. Gastroenterology Research and Practice. 2021;2021(1):6641023.
18. 18. Brouwers L, Koster MPH, Page-Christiaens GCML,Kemperman H, Boon J, Evers IM, et al. Intrahepatic cholestasisof pregnancy: maternal and fetal outcomes associated withelevated bile acid levels. American Journal of Obstetrics &Gynecology. 2015 Jan 1;212(1):100.e1-100.e7.
19. 19. Chen Y, Zhang H, Ning W, Chen Y, Wen C. The impact ofintrahepatic cholestasis on pregnancy outcomes: a retrospectivecohort study. BMC Gastroenterology. 2023 Jan 18;23(1):16.
20. 20. Al-Obaidly S, Salama H, Olukade T, AlQubaisi M, Bayo A, AlRifai H. Perinatal outcomes of intrahepatic cholestasis ofpregnancy from two birth cohorts: A population-based study.Obstet Med. 2022 Dec;15(4):248–52.